A decision by the FDA will allow the painkiller to stay on the market until a replacement painkiller is approved.
Wired PR News – The Food and Drug Administration (FDA) has reversed last week’s order to stop the manufacturing of liquid morphine. As reported by the Associated Press (AP), the FDA stated that the painkiller will stay on the market until a substitute is approved.
Liquid morphine was one of 14 medications the agency was planning to order manufacturers to stop making, all of which had never been approved by the FDA.
As noted in the report, many pain relief and hospice care experts were happy about the decision due to the relief liquid morphine provides to patients who are dying or in extreme pain. Dr. Porter Story with the American Academy of Hospice and Palliative Medicine is quoted by the AP as stating the FDA decision is “a really important step in the right direction” that demonstrates, “an amazing level of responsiveness we’re not used to seeing in our government officials.”
